Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical liposomal azithromycin versus intralesional meglumine antimoniate for cutaneous leishmaniasis
IRCT138901312082N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of azithromycin and meglumine antimoniate in cutaneous leishmaniasis (CL) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Dec 2009; status: completed.
02
Drugs
azithromycinmeglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT138901312082N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901312082N2.